Effect of systemic and intrastriatal injections of haloperidol on striatal dopamine and DOPAC concentrations in rats pretreated by section of nigrostriatal fibres.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000032:analysis*; D000818:Animals; D003342:Corpus Striatum / Q000032:analysis / Q000187:drug effects / Q000502:physiology*; D004298:Dopamine / Q000032:analysis* / Q000378:metabolism; D005246:Feedback; D005968:Glutamate Decarboxylase / Q000032:analysis; D006220:Haloperidol / Q000008:administration & dosage / Q000494:pharmacology*; D007608:Kainic Acid / Q000494:pharmacology; D008297:Male; D009410:Nerve Degeneration; D010648:Phenylacetates / Q000032:analysis*; D051381:Rats; D011954:Receptors, Dopamine / Q000502:physiology; D013378:Substantia Nigra / Q000187:drug effects / Q000502:physiology*
D010648:Phenylacetates; D011954:Receptors, Dopamine; D015102:3,4-Dihydroxyphenylacetic Acid; D005968:Glutamate Decarboxylase; D006220:Haloperidol; D007608:Kainic Acid; D004298:Dopamine